• Skip to main content
Daily Citizen
  • Subscribe
  • Categories
    • Culture
    • Life
    • Religious Freedom
    • Sexuality
  • Parenting Resources
    • LGBT Pride
    • Homosexuality
    • Sexuality/Marriage
    • Transgender
  • About
    • Contributors
    • Contact
  • Donate

WPATH

Jun 22 2026

WPATH Pushed Sex-Rejecting Procedures on Kids for Financial Gain, FTC Lawsuit Alleges

The Federal Trade Commission (FTC) sued the World Professional Association for Transgender Health (WPATH) last week for making “false and unsubstantiated” statements which enabled the promotion of sex-rejecting procedures to minors.

The lawsuit, which Alaska, Iowa, Nebraska and Texas joined, alleges WPATH’s Standards of Care, Version 8 (SOC-8), the group’s treatment recommendations for transgender-identified people, deceived families about the scientific support for and effectiveness of pediatric sex-rejecting procedures — including puberty blocking drugs, opposite-sex hormones and surgeries.

The FTC isn’t the first to lay out SOC-8’s blatant scientific deficiencies. It is, however, one of the first to assign WPATH an alleged motive for pushing sex-rejecting procedures on American families and children: cold, hard cash.

The filing asserts:

WPATH misrepresents scientific and medical consensus and makes false, deceptive or unsubstantiated claims regarding [sex-rejecting procedures for kids] and related services for a simple reason: WPATH’s members generate significant profit because of the organization’s representations and guidance.

The vast majority of WPATH members work in the “transgender” procedures industry. Some, including three of five members of WPATH’s executive committee, perform sex-rejecting procedures. Others work in related businesses, like “gender-affirming” counseling.

WPATH lines its members’ pockets by legitimizing and expanding access to sex-rejecting procedures. According to the FTC, this has always been WPATH’s purpose, dating back to its inception in 1979.

That year was a disastrous one for the burgeoning “transgender” procedures industry. Johns Hopkins University closed down its “Gender Identity Clinic,” which opened in 1966, after a university psychiatrist published a paper “showing no objective benefit to transition.”

Other clinics followed suit, reflecting general unease over difficulty diagnosing “dissatisfaction with one’s sex traits” and inability to determine which patients would benefit from sex-rejecting procedures.

Lack of academic backing prompted insurance companies to stop covering the experimental interventions — drastically limiting the number of people who could purchase them.

The FTC’s filing claims members of the floundering “transgender” procedures industry created WPATH to recreate a semblance of academic support for their dangerous, experimental medical interventions.

The group published its first Standards of Care in 1981 to establish itself as an academic authority. In the four decades since, it has successfully masqueraded as an expert medical group, rather than a profit-driven industry lobby.

Until very recently, WPATH had nearly unilateral power to determine accepted standards of care for transgender-identified people, including what procedures insurance companies paid for. The Department of Health and Human Services’ 2025 report on the harms of sex-rejecting procedures for minors notes, “Many U.S. public and private health insurers and regulatory bodies rely on SOC-8 when making coverage determinations.”

The FTC alleges WPATH used this power to gradually expand its customer base.

In 2008, for instance, WPATH first declared opposite-sex hormones and sex-rejecting surgeries “medically necessary,” a term which generally triggers insurance coverage.

Less than two decades later, the FTC notes, SOC-8 encourages insurance companies to consider “‘medically necessary’ virtually every pediatric medical transition service that a transition doctor could perform for a fee,” including “gender affirming hair removal.”

WPATH members have also made untold millions by performing sex-rejecting procedures on kids. Lowering age limits on transgender medical interventions gives doctors a chance to cash in on the temporary sexual identity confusion kids often face.

The filing explains.

Pediatric medical transition is a profitable market for [doctors who perform sex-rejecting procedures], because most children will naturally desist, or cease experiencing discomfort with or distress about their sex traits, if clinicians delay medical transition procedures.

Similarly, if a doctor administers puberty blockers to a child, they are significantly more likely receive opposite-sex hormones and sex-rejecting surgical procedures.

The estimated lifetime cost of “transgender” medical interventions for a man ranges from $75,000 to nearly $411,000, according to the filing. For a woman, the range is even wider, spanning from about $67,000 to as much as $606,000.

“WPATH has long represented itself as the final authority for the gender-related treatment of children, advancing profit-driven ideology unsupported by science and withholding crucial information from children, parents and doctors,” Nebraska Attorney General Mike Hilgers wrote in a press release.

“We’re proud to work with the Federal Trade Commission and state attorneys general to hold WPATH accountable for deceiving parents and medical professionals and causing harm to children and nationwide.”

“Patients and their families have been deceived into believing the organization is an authoritative, medical body, when, in truth, their recommendations are based on politics and ideology,” Iowa Attorney General Brenna Bird added.

“Parents and children deserve better.”

The Daily Citizen couldn’t agree more. We thank the FTC, Alaska, Iowa, Nebraska and Texas for bringing this action in service of children and families harmed by WPATH. Please pray justice be done in this case.

Additional Articles and Resources

FTC Begins Investigating ‘Gender Affirming’ Medical Community for Deception, False Advertising

Activist Group WPATH Influences Judgement in Case of Prisoner Receiving Trans Surgery

Suicidal or Stable? WPATH Activist’s Contradictory Evaluation Secures Felon Transgender Surgery

The WPATH Files Exposes ‘Surgical and Hormonal Experiments on Children’

The WPATH Files – Transgender Interventions Are ‘Unethical Medical Experiments’

Transgender Organization Suggests Hormones and Surgeries Should Start Even Earlier for Gender-Confused Teens

Do Not Fall for the ‘Affirm Them or They Will Die’ Lie

Written by Emily Washburn · Categorized: Culture · Tagged: transgender, WPATH

May 02 2025

HHS Releases Report on Harms of ‘Transgender’ Medical Interventions for Minors

The U.S. Department of Health and Human Services (HHS) released an important evaluation of the evidence for how best to treat children and adolescents with “gender dysphoria.”

Not surprisingly, the comprehensive review, Treatment for Pediatric Gender Dysphoria Review of Evidence and Best Practices, showed serious problems with treating minors with “gender-affirming care,” which can include body damaging, experimental and risky puberty suppressants, hormones and surgeries.

A news release from HHS clearly explained the troubling paucity of evidence and grave risks for confused children who receive these medical interventions:

This review, informed by an evidence-based medicine approach, reveals serious concerns about medical interventions, such as puberty blockers, cross-sex hormones, and surgeries, that attempt to transition children and adolescents away from their sex.

The review highlights a growing body of evidence pointing to significant risks – including irreversible harms such as infertility – while finding very weak evidence of benefit. That weakness has been a consistent finding of systematic reviews of evidence around the world.

Treatment for Pediatric Gender Dysphoria is 409 pages long and covers everything from the history of transgender medicine to current treatment practices to the effects of harmful medical interventions on minors. It’s release was accompanied by a 173-page appendix which explained the methodology and gave a synthesis of the evidence.

Director of the National Institutes of Health Dr. Jay Bhattacharya emphasized the primary goal in treating children with sexual identity confusion should be to safeguard their health.

He said, “Our duty is to protect our nation’s children – not expose them to unproven and irreversible medical interventions. We must follow the gold standard of science, not activist agendas.”

The report explains that activist agenda comes from groups like the Endocrine Society, the American Academy of Pediatrics, and the World Professional Association for Transgender Health (WPATH). These groups have labeled their treatment “gender-affirming care,” which means affirming a child’s sexual identity confusion and allowing the child to try to live as the opposite sex, or a combination of the two sexes, or no sex, or some self-defined, pseudo “gender.”

These minors are then encouraged to use dangerous and powerful puberty blockers, proceed to body-damaging opposite sex hormones, and then undergo irreversible surgeries. An executive summary of the literature review states the seriousness of these treatments for children who have nothing wrong with their brains or bodies:

Nevertheless, the “gender-affirming” model of care includes irreversible endocrine and surgical interventions on minors with no physical pathology.

These interventions carry risk of significant harms including infertility/sterility, sexual dysfunction, impaired bone density accrual, adverse cognitive impacts, cardiovascular disease and metabolic disorders, psychiatric disorders, surgical complications, and regret.

The executive summary explains that there is little evidence that “gender-affirming” care is even helpful.

“Meanwhile, systematic reviews of the evidence have revealed deep uncertainty about the purported benefits of these interventions.”

One section of the extensive report details the “International Retreat from the ‘Gender-Affirming’ Model,” known as the Dutch Protocol, first published in 2006, which advocated for “gender-affirming care.” This medicalized approach initially expanded, based on two flawed, unreplicated studies with “serious limitations.”

In 2015, the meta-analysis explains, the number of youth identifying as “transgender” surged dramatically, “first gradually, then suddenly,” with a large number of female adolescents wanting to live as boys.

Given its shaky foundation researchers in different countries began conducting their own studies of “gender-affirming care,” and the report details the growing international movement away from using medical interventions to modify children’s bodies:

Finland subsequently became the first country to revise its national guidelines, sharply limiting medical interventions based on the findings of an SR [systematic review]. In the years that followed, other countries began conducting their own evaluations of the evidence and arrived at similar conclusions.

A global trend has since emerged, away from use of PBs [puberty blockers], CSH [cross-sex hormones], and surgeries in youth with GD [gender dysphoria].

Treatment for Pediatric Gender Dysphoria describes England’s review of “pediatric gender medicine” that began in 2020, with the final report, The Cass Review released in 2024. This led to the closing of the country’s Gender Identity Development Service and a move away from puberty blockers, hormones and surgeries for children.

The new HHS report lists other countries that have stopped or limited these harmful, disfiguring treatments, including Denmark, Sweden, and Norway, adding,

“Most recently, hormonal interventions have been restricted in Brazil, Chile, the province of Alberta in Canada, and the state of Queensland in Australia.”

The meta-analysis makes clear that it is not a clinical practice guideline, while emphasizing it “describes the very low-quality evidence underpinning treatment approaches in pediatric gender medicine” and “contains an extensive description of potential or plausible harms associated with certain treatment options (namely, hormonal interventions and surgeries), some of which are significant.”

It concludes that current transgender medical interventions for children and adolescents “are inconsistent with widely endorsed principles of medical ethics.”

There’s much more in Treatment for Pediatric Gender Dysphoria Review of Evidence and Best Practices, and the Daily Citizen will detail these findings in the weeks ahead.

Related Articles and Resources

If you or someone you know is struggling with transgenderism, Focus on the Family offers a one-time complimentary consultation with our ministry’s professionally trained counseling staff. The consultation is free due to generous donor support.

To reach Focus on the Family’s counseling service by phone, call 1-855-771-HELP (4357) weekdays 6:00 a.m. to 8:00 p.m. (Mountain Time). Please be prepared to leave your contact information for a counselor to return a call to you as soon as possible. Alternatively, you can fill out our Counseling Consultation Request Form.

Addressing Gender Identity with Honesty and Compassion

Cakegender? Genderfaun? Orbgender?

Colorado Counselor Asks U.S. Supreme Court to Hear Free Speech Case

Counseling for Sexual Identity Concerns: A Measured, Careful, and Compassionate Approach.

The Journey Back to My True Identity

New Video Equips Parents and Counselors to Help ‘Gender Dysphoric’ Children

Questioning Drugs, Hormones and Surgery for Youth Confused about Their Sexual Identity

The Shifting Ground of ‘Gender-Affirming Care’

Transgenderism and Minors: What Does the Research Really Show?

UK Bans Puberty Blockers for ‘Transgender’ Minors

U.K.’s Review of Child Gender Policy Reveals Profound Failures That U.S. Still Defends

What is ‘Gender Identity’

Written by Jeff Johnston · Categorized: Culture · Tagged: LGBT, transgender, WPATH

Mar 14 2025

Judge Disregards Vital Testimony in Case of Gender-Confused Felon — Again

To read more about Jonathan Richardson’s case, check out the stories linked at the bottom of this article.

A federal district judge has disregarded yet another evaluation showing Jonathan Richardson, a mentally-ill man incarcerated for murder, should not get transgender surgery — especially on taxpayers’ dime.

On March 5, Judge Richard Young of the Southern District Court of Indiana extended his preliminary injunction against a state law preventing tax dollars from funding transgender surgeries.

Young first issued the injunction in September when he ordered the Indiana Department of Corrections (IDOC), a tax-funded institution, to pay for Richardson’s “gender-affirming” vaginoplasty (the construction of a fake vagina) and orchiectomy (castration).

Refusing Richardson surgery would constitute cruel and unusual punishment, Young wrote in his September ruling.

The IDOC opposed this month’s extension, submitting yet another psychiatric evaluation of Richardson finding he shouldn’t get transgender surgery.

Dr. Kelsey Beers, the lead psychologist at New Castle Correctional Facility, conducted an assessment of Richardson at the request of Richardson’s would-be surgeon. According to Young’s nine-page order, Beers concluded:

Richardson’s purported distress is actually a manifestation of [his] Antisocial Personality Disorder and Borderline Personality Disorder and that he “displays an established pattern of attention-seeking behavior.”

Beers expressed discomfort at evaluating Richardson without specializing in gender dysphoria. But her conclusions mirror that of Drs. Steven Levine and Michael Farjellah, who evaluated Richardson ahead of the hearing in September.

Farjellah claimed Richardson’s borderline personality disorder made him unable to consent to such drastic surgery.

Levine, a former member of WPATH’s predecessor, the Harry Benjamin International Gender Dysphoria Association, concluded Richardson’s gender confusion was sufficiently managed by opposite-sex hormones and therapy.

He suggested more therapy be dedicated, in part, to Richardson’s “…. willingness to manipulate and mislead doctors.”

Young found Farjellah and Levine’s arguments “unpersuasive.” Last week, he found Beers’ qualifications “questionable” and her revelations about Richardson’s personality disorders “nothing new.”

The judge’s decision is flabbergasting, but also predictable. As the Daily Citizen previously reported, Young’s adjudication of the case is hopelessly skewed by his reliance on the World Professional Association for Transgender Health (WPATH).

WPATH bills itself as an objective, scientific body dedicated to caring for those with gender dysphoria. In reality, its members, affiliates and researchers are ideologically and financially invested in transgender medical interventions.

Judge Young hasn’t clocked this conflict of interest. Instead, he disregards the testimony of every doctor that disagrees with WPATH’s “surgery at all costs” orientation.

Case in point: the judge found Dr. Randi Ettner’s testimony “credible and persuasive.”

Ettner, a WPATH contributor and employee at the Weiss Memorial Hospital Center for Gender Confirmation Surgery, painted Young two categorically opposed pictures of Richardson’s mental state in September.

The surgeries were “medically necessary,” Ettner argued, because Richardson could commit suicide if he didn’t go under the knife — a common refrain among gender idealogues. She simultaneously claimed he was mentally well enough to consent to surgery because his depression and personality disorders were under control.

Ettner even portrayed Richardson’s attempt to castrate himself as evidence of his healthy mind. She told Judge Young:

[These actions] should not be considered a sign of “uncontrolled mental illness”: on the contrary, such behavior represents a rational intention to eliminate testosterone by removal of the androgen-producing target organ.

I’m no expert, but I’m 200% sure self-castration isn’t a sign of rationality. That statement alone should have disqualified Ettner’s testimony — and maybe barred her from courtrooms altogether.

But even overlooking the castration kerfuffle, Ettner’s larger argument is coconuts. Richardson cannot simultaneously be mentally ill enough to commit suicide if he doesn’t receive “gender affirming” surgery and mentally well enough to consent to such interventions.

Interestingly, Beers’ wrote of a December 2024 counseling session in which Richardson was “clinically stable…with no remarkable symptoms of depression or anxiety.”

Judge Young did not take this testimony as evidence Richardson is doing perfectly well without a faux vagina. Instead, he doubled down on Ettner’s perspective — that Richardson’s stability simply confirms he can consent to transgender surgery.

I’m not the only one concerned about Young’s decision making. Indiana Attorney General Todd Rokita appealed the ruling in October.

“[The Eighth Amendment doesn’t require] the state to provide experimental treatments generally, and it certainly doesn’t here, when multiple doctors have said this inmate is a poor candidate for surgery,” he argues.

Rokita doubled down on his stance this week, telling Fox:

Convicted murderers don’t get to demand that taxpayers foot the bill for expensive and controversial sex-change operations. It lacks all common sense. We won’t stop defending our state’s ban on using taxpayer funds to provide sex-change surgeries to prisoners.

In his order, Young writes he will extend the preliminary injunction until Richardson gets his surgery. That means taxpayers are still on the hook, unless the Indiana Court of Appeals overturns Young’s ruling first.

Please pray common sense — and speed — will have their day in Indiana soon.

Additional Articles and Resources

Indiana AG Appeals Ruling in Case of Gender-Confused Felon

Taxpayers Will Fund Violent Inmate’s Transgender Surgery, Judge Rules

Activist Group WPATH Influences Judgement in Case of Prisoner Receiving Trans Surgery

Suicidal or Stable? WPATH Activist’s Contradictory Evaluation Secures Felon Transgender Surgery

The WPATH Files Exposes ‘Surgical and Hormonal Experiments on Children’

The WPATH Files – Transgender Interventions Are ‘Unethical Medical Experiments’

Written by Emily Washburn · Categorized: Culture · Tagged: transgender, WPATH

Privacy Policy and Terms of Use | Privacy Policy and Terms of Use | © 2026 Focus on the Family. All rights reserved.

  • Cookie Policy